71 related articles for article (PubMed ID: 7536389)
1. Treatment of metastasized midgut carcinoids with dacarbazine.
Ritzel U; Leonhardt U; Stöckmann F; Ramadori G
Am J Gastroenterol; 1995 Apr; 90(4):627-31. PubMed ID: 7536389
[TBL] [Abstract][Full Text] [Related]
2. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
Jensen EH; Kvols L; McLoughlin JM; Lewis JM; Alvarado MD; Yeatman T; Malafa M; Shibata D
Ann Surg Oncol; 2007 Feb; 14(2):780-5. PubMed ID: 17146740
[TBL] [Abstract][Full Text] [Related]
4. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
5. Octreotide exerts only acute, but no sustained, effects on MRI enhancement of liver metastases in carcinoid syndrome.
Zomerhuis MT; Hussain SM; Feelders RA; van der Lely AJ; de Herder WW
Neuroendocrinology; 2005; 82(1):41-8. PubMed ID: 16391492
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine.
van Hazel GA; Rubin J; Moertel CG
Cancer Treat Rep; 1983 Jun; 67(6):583-5. PubMed ID: 6861165
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
9. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
10. [Three cases of multiple liver metastases of carcinoid tumor responding to hepatic arterial infusion chemotherapy using degradable starch microspheres].
Takanashi K; Homma H; Mezawa S; Doi T; Akiyama T; Machida T; Murakami K; Hirata K; Iyama S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2358-61. PubMed ID: 12484074
[TBL] [Abstract][Full Text] [Related]
11. DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
Altimari AF; Badrinath K; Reisel HJ; Prinz RA
Surgery; 1987 Dec; 102(6):1009-17. PubMed ID: 2825370
[TBL] [Abstract][Full Text] [Related]
12. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
[TBL] [Abstract][Full Text] [Related]
13. [A case of liver metastases of rectal carcinoid successfully treated with hepatic arterial infusion of methotrexate and 5-fluorouracil].
Takeuchi I; Ishida H; Suzuki T; Nakada H; Tada M; Idezuki Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1929-32. PubMed ID: 10560428
[TBL] [Abstract][Full Text] [Related]
14. Gastrinoma with multiple liver metastases: effectiveness of dacarbazine (DTIC) therapy.
Ohshio G; Hosotani R; Imamura M; Sakahara H; Ochi J; Kubota N
J Hepatobiliary Pancreat Surg; 1998; 5(3):339-43. PubMed ID: 9880785
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic, surgical and medical aspect of the midgut carcinoids.
de Vries H; Verschueren RC; Willemse PH; Kema IP; de Vries EG
Cancer Treat Rev; 2002 Feb; 28(1):11-25. PubMed ID: 12027412
[TBL] [Abstract][Full Text] [Related]
16. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal carcinoids: extrahepatic metastases and symptomatology following resection.
Dilawari RA; Douglass HO
J Surg Oncol; 1979; 11(3):243-8. PubMed ID: 156820
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.
Bukowski RM; Tangen CM; Peterson RF; Taylor SA; Rinehart JJ; Eyre HJ; Rivkin SE; Fleming TR; Macdonald JS
Cancer; 1994 Mar; 73(5):1505-8. PubMed ID: 8111718
[TBL] [Abstract][Full Text] [Related]
19. Interferon treatment in patients with malignant carcinoids.
Nobin A; Lindblom A; Månsson B; Sundberg M
Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
